Join us on Twitter on Tuesday, May 24 at 10 a.m. for the first monthly #SUDClinicianChat. This month we will be discussing Co-Occurring Disorders. Over the course of the chat, we will be asking a series of questions about the experience clinicians have working with individuals who have co-occurring substance use and mental health disorders. […]
Much of the recent discourse in the addiction treatment and recovery community has touched upon the record-breaking rise in overdose deaths in the United States, as well as the sharp uptick in alcohol use that came about at the beginning of the COVID-19 pandemic. But very rarely is alcohol discussed as being a part of […]
In President Biden’s March 1st State of the Union address, the opioid epidemic was discussed as one of four bi-partisan issues which the nation could unify. President Biden went on to explain strategies that can be done to combat the crisis of opioid use and overdose. “There is so much we can do. Increase funding […]
There is a recognizable need for improved treatment for substance use disorder in the United States. Drug overdose deaths are at an all-time high and standardization of the delivery and coverage for addiction treatment can be hard to find. Unfortunately, as it stands, addiction treatment and reimbursement practices can vary greatly from state to state, […]
Thanks to COVID-19 vaccines, this year’s holiday season is likely to feel more “normal” than last year, with family gatherings, holiday parties, and many other traditional festivities making a cautious return. For people in recovery from a substance use disorder, the holidays can be an especially difficult time for a number of reasons. Parties, gatherings, […]
Women have increased their heavy drinking days by 41%. The pandemic is partly to blame, but the problem didn’t start there.
Research shows that LGBTQ youth are two to four times more likely to use substances than their heterosexual and cisgender peers. Find out why and learn what kinds of support help most.
The COVID-19 pandemic has presented challenges and opportunities for substance disorder treatment. IRETA and Vital Strategies are studying effects of OTP rule changes.
The National Institutes of Health (NIH) released a study that shows a combination of two medications, injectable naltrexone and oral bupropion, is safe and effective in treating methamphetamine use disorder.
IRETA faced the challenge of switching completely to telehealth with very little notice. IRETA’s Director of Clinical Quality Improvement Services, David Reazin, MHS, answered questions about what it was like to adapt to telehealth and the pros and cons of virtual groups.